Recombinant factor IX-Fc fusion protein in severe hemophilia B: Patient-reported outcomes and health-related quality of life

CONCLUSION: This study of real-world patient experience using PROs demonstrates a reduction in chronic pain and improvement in ADLs in participants after switching to rFIXFc prophylaxis. It provides important insights into patient-identified health care needs and living with severe hemophilia B.PMID:34667923 | PMC:PMC8505226 | DOI:10.1002/rth2.12602

Source: Thrombosis and Haemostasis - October 20, 2021 Category: Hematology Authors: Mairead O'Donovan Eimear Quinn Kate Johnston Evelyn Singleton Julie Benson Brian O'Mahony Declan Noone Cleona Duggan Ruth Gilmore Kevin Ryan James S O'Donnell Niamh M O'Connell Johnny Mahlangu Source Type: research